Developer docs
API playgroundTry for free, no card

Search company profiles

Spero

Full company profile

uuid02miuf7

Namestring
Spero
Legal namestring
Spero Inc. (스페로(주))
Websiteurl
ispero.io
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Spero Inc. (스페로(주)) is a South Korea-based clinical research organization (CRO) founded in 2022 that provides decentralized clinical trial (DCT) services and integrated clinical trial management solutions to pharmaceutical and biotech sponsors. The firm operates a platform-plus-modules architecture centered on its proprietary iSPERO / SPERO DCT platform, supplemented by cubeCONSENT 3.0 for electronic informed consent, VIA/cubeRBQM for centralized monitoring and risk-based quality management (120+ default KRIs with EDC integration), ePRO for electronic patient-reported outcomes, and MediCLEO for patient recruitment (140+ studies delivered). It also delivers a full-service CRO suite covering medical writing, project management, study start-up, site management and monitoring, data management, biostatistics, quality assurance, centralized monitoring and consulting.

Spero runs on a professional services / managed services revenue model with custom quotation, multi-year enterprise contracts, and sales-led B2B direct engagement — typically responding to clinical trial inquiries within 24 business hours via dedicated contact channels (help@ispero.io and marketing@ispero.io). Its core technology partnership with CRScube Inc. provides cubeCDMS (clinical data management system) and cubeCONSENT 3.0, with VIA/cubeRBQM offering interlocking integration with cubeCDMS and broader EDC system data import.

The company targets the Korean clinical trial market primarily, evidenced by MFDS-focused regulatory positioning, Korean-language website, KoNECT-MOHW-MFDS and MFDS/KSCD conference participation, and KIC Exhibition presence. AWS infrastructure was migrated to Japan and Singapore regions in September 2023, suggesting preparation for cross-border trial operations. Marketing is concentrated in content-led channels: website, annual webinars, industry conferences, a SPERO NEWS newsletter and a published resource library including MFDS electronic consent Q&A documentation. No disclosed funding rounds, named customers, or revenue figures were identified in the available sources.

Short descriptiontext

Spero Inc. is a South Korea-based clinical research organization founded in 2022 that delivers decentralized clinical trial services and integrated CRO technology (eConsent, ePRO, centralized monitoring, patient recruitment) to pharmaceutical and biotech sponsors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
decentralized clinical trials, clinical research organization, risk-based quality monitoring, electronic informed consent, clinical trial patient recruitment
Industry2 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Organization (CRO) / Decentralized Clinical Trial Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Development Services
TypeProfessional Services
Description

Full-service CRO offerings including Medical Writing, Project Management, Study Start-Up, Site Management & Monitoring, Data Management, Biostatistics, Quality Assurance, Centralized Monitoring, and Consulting Services. Provided on a project/contract basis to pharmaceutical and biotech sponsors.

ispero.io
2Clinical Trial Solutions
TypeManaged Services
Description

Technology-enabled solutions including DCT platform access, eConsent, ePRO, patient recruitment services (MediCLEO), and centralized monitoring (VIA/cubeRBQM). Sold as integrated service packages to clinical trial sponsors.

ispero.io
3Clinical Trial Consultation
TypeProfessional Services
Description

Consulting services for clinical trial operations, decentralized clinical trials, centralized monitoring, and patient recruitment. Provided through direct inquiry and consultation requests.

ispero.io
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Custom quotation based on project scope
ModelOtherBilling cadenceMulti-year contract
Notes

Contact-based pricing for CRO services, DCT solutions, centralized monitoring, and patient recruitment services.

ispero.io
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1iSPERO
Description

Decentralized clinical trial platform

ispero.io
+3 more records
Core offering1 text field

Spero is a clinical research organization that delivers integrated decentralized clinical trial (DCT) solutions to pharmaceutical and biotech sponsors. It combines traditional clinical development services (medical writing, project management, study start-up, site management and monitoring, data management, biostatistics, quality assurance, centralized monitoring, and consulting) with proprietary digital tools including the iSPERO DCT platform, VIA/cubeRBQM centralized monitoring, cubeCONSENT 3.0 electronic consent, ePRO, and the MediCLEO patient recruitment service.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • MediCLEO patient recruitment service has completed over 140 clinical studies
Product overview1 text field

Spero is a dedicated Decentralized Clinical Trial (DCT) CRO providing integrated clinical trial solutions. The company operates a platform-plus-modules architecture combining a proprietary decentralized clinical trial platform (SPERO DCT / iSPERO) with specialized add-on solutions including VIA/cubeRBQM for centralized monitoring and risk-based quality management, cubeCONSENT 3.0 for electronic informed consent, ePRO for patient-reported outcomes, and MediCLEO for patient recruitment. Supporting these digital solutions is a comprehensive suite of clinical development services covering Medical Writing, Project Management, Study Start-Up, Site Management & Monitoring, Data Management, Biostatistics, Quality Assurance, Centralized Monitoring, and Consulting. The portfolio enables hybrid digital clinical trials that integrate traditional site-based operations with decentralized elements for improved participant convenience and data quality.

Product and service14 records
1SPERO DCT (iSPERO)
CategoryDecentralized Clinical Trial Platform
2VIA / cubeRBQM
CategoryCentralized Monitoring / Risk-Based Quality Management
3MediCLEO
CategoryPatient Recruitment Service
4cubeCONSENT 3.0
CategoryElectronic Informed Consent
5ePRO (Electronic Patient-Reported Outcome)
CategoryElectronic Patient-Reported Outcomes
6Medical Writing
CategoryClinical Development Services
7Project Management
CategoryClinical Development Services
8Study Start-Up
CategoryClinical Development Services
9Site Management & Monitoring
CategoryClinical Development Services
10Data Management
CategoryClinical Development Services
11Biostatistics
CategoryClinical Development Services
12Quality Assurance
CategoryClinical Development Services
13Centralized Monitoring (service)
CategoryClinical Development Services
14Consulting Service
CategoryConsulting Services
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-01-01
Description

CRScube is a technology partner providing cubeCDMS (clinical data management system) and cubeCONSENT 3.0 electronic consent solution. Spero's VIA centralized monitoring solution has interlocking integration with cubeCDMS. The companies collaborate on DCT solutions with cubeCONSENT supporting electronic informed consent procedures integrated with Spero's clinical trial services.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

CRScube provides cloud server and web hosting services to Spero under a data processing delegation agreement. Services include customer support, technical measures for personal information safety including access control, encryption, and security program updates. Partnership supports Spero's digital infrastructure for clinical trial operations.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global full-service CRO and clinical technology provider with extensive DCT capabilities through the IQVIA Decentralized Clinical Trials platform. Highly relevant as a broad incumbent that competes for the same pharma/biotech sponsors Spero targets, albeit at vastly larger scale.

TypeBroad incumbent
Description

Large global CRO offering full-service clinical development plus decentralized and patient-centric trial solutions. Overlaps with Spero's CRO service portfolio (medical writing, monitoring, biostatistics, data management) for pharma and biotech sponsors.

TypeBroad incumbent
Description

Clinical trial technology platform (Rave EDC, eCOA, eConsent, RBQM) widely used by sponsors and CROs. Direct overlap with Spero's iSPERO DCT platform, ePRO, eConsent, and VIA/cubeRBQM functionality, though Medidata is primarily a software provider serving many CROs.

TypeDirect peer
Description

Dedicated decentralized clinical trial platform offering eConsent, eCOA, telehealth, and patient experience modules. Closely comparable to Spero's iSPERO stack in product scope and target customer (pharma/biotech sponsors running DCT and hybrid trials).

TypeDirect peer
Description

DCT-native CRO and platform provider offering unified trial orchestration, eConsent, eCOA, and decentralized site services. Directly comparable to Spero's integrated CRO + DCT platform model.

TypeEmerging player
Description

Korean clinical trial technology provider whose cubeCDMS, cubeCONSENT 3.0, and hosting services are integrated into Spero's iSPERO and VIA offerings. Adjacent competitor and partner in the Korean DCT ecosystem with overlapping DM and eConsent capabilities.

TypeDirect peer
Description

Clinical trial endpoint technology and decentralized trial solutions provider with eCOA, medical imaging, and RBQM capabilities. Directly comparable to Spero's ePRO and centralized monitoring modules within a DCT offering.

TypeBroad incumbent
Description

Spin-off of Labcorp's clinical development business, providing full-service CRO services including decentralized trial enablement. Overlaps with Spero's full-service CRO portfolio (PM, monitoring, biostatistics, DM) at larger global scale.

9Oracle Health Sciences
TypeBroad incumbent
Description

Provider of EDC (Oracle Clinical One), eClinical platform, and clinical trial analytics used by sponsors and CROs. Competes with Spero's data management, EDC integration, and centralized monitoring capabilities.

TypeEmerging player
Description

DCT-focused clinical trial platform and provider offering eConsent, eCOA, remote monitoring, and a hybrid CRO service model. Comparable emerging peer with overlapping product modules and a similar SMB-CRO positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Spero

Clinical Research Organization (CRO) / Decentralized Clinical Trial Servicesispero.io

Spero Inc. is a South Korea-based clinical research organization founded in 2022 that delivers decentralized clinical trial services and integrated CRO technology (eConsent, ePRO, centralized monitoring, patient recruitment) to pharmaceutical and biotech sponsors.

What Spero does

Spero Inc. (스페로(주)) is a South Korea-based clinical research organization (CRO) founded in 2022 that provides decentralized clinical trial (DCT) services and integrated clinical trial management solutions to pharmaceutical and biotech sponsors. The firm operates a platform-plus-modules architecture centered on its proprietary iSPERO / SPERO DCT platform, supplemented by cubeCONSENT 3.0 for electronic informed consent, VIA/cubeRBQM for centralized monitoring and risk-based quality management (120+ default KRIs with EDC integration), ePRO for electronic patient-reported outcomes, and MediCLEO for patient recruitment (140+ studies delivered). It also delivers a full-service CRO suite covering medical writing, project management, study start-up, site management and monitoring, data management, biostatistics, quality assurance, centralized monitoring and consulting.

Spero runs on a professional services / managed services revenue model with custom quotation, multi-year enterprise contracts, and sales-led B2B direct engagement — typically responding to clinical trial inquiries within 24 business hours via dedicated contact channels (help@ispero.io and marketing@ispero.io). Its core technology partnership with CRScube Inc. provides cubeCDMS (clinical data management system) and cubeCONSENT 3.0, with VIA/cubeRBQM offering interlocking integration with cubeCDMS and broader EDC system data import.

The company targets the Korean clinical trial market primarily, evidenced by MFDS-focused regulatory positioning, Korean-language website, KoNECT-MOHW-MFDS and MFDS/KSCD conference participation, and KIC Exhibition presence. AWS infrastructure was migrated to Japan and Singapore regions in September 2023, suggesting preparation for cross-border trial operations. Marketing is concentrated in content-led channels: website, annual webinars, industry conferences, a SPERO NEWS newsletter and a published resource library including MFDS electronic consent Q&A documentation. No disclosed funding rounds, named customers, or revenue figures were identified in the available sources.

Spero firmographics

Firmographics
Name
Spero
Legal name
Spero Inc. (스페로(주))
Website
https://ispero.io
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
Spero Inc. is a South Korea-based clinical research organization founded in 2022 that delivers decentralized clinical trial services and integrated CRO technology (eConsent, ePRO, centralized monitoring, patient recruitment) to pharmaceutical and biotech sponsors.
Ownership category
akta.pro rank

Spero industry classification

Industry
Product category
Clinical Research Organization (CRO) / Decentralized Clinical Trial Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Decentralized clinical trials
  • Clinical research organization
  • Risk-based quality monitoring
  • Electronic informed consent
  • Clinical trial patient recruitment

Where Spero is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

Spero business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Clinical Development Services: Full-service CRO offerings including Medical Writing, Project Management, Study Start-Up, Site Management & Monitoring, Data Management, Biostatistics, Quality Assurance, Centralized Monitoring, and Consulting Services. Provided on a project/contract basis to pharmaceutical and biotech sponsors.
  2. Clinical Trial Solutions: Technology-enabled solutions including DCT platform access, eConsent, ePRO, patient recruitment services (MediCLEO), and centralized monitoring (VIA/cubeRBQM). Sold as integrated service packages to clinical trial sponsors.
  3. Clinical Trial Consultation: Consulting services for clinical trial operations, decentralized clinical trials, centralized monitoring, and patient recruitment. Provided through direct inquiry and consultation requests.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom quotation based on project scope

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Spero product offering

Product offering

Core offering

Spero is a clinical research organization that delivers integrated decentralized clinical trial (DCT) solutions to pharmaceutical and biotech sponsors. It combines traditional clinical development services (medical writing, project management, study start-up, site management and monitoring, data management, biostatistics, quality assurance, centralized monitoring, and consulting) with proprietary digital tools including the iSPERO DCT platform, VIA/cubeRBQM centralized monitoring, cubeCONSENT 3.0 electronic consent, ePRO, and the MediCLEO patient recruitment service.

Product overview

Spero is a dedicated Decentralized Clinical Trial (DCT) CRO providing integrated clinical trial solutions. The company operates a platform-plus-modules architecture combining a proprietary decentralized clinical trial platform (SPERO DCT / iSPERO) with specialized add-on solutions including VIA/cubeRBQM for centralized monitoring and risk-based quality management, cubeCONSENT 3.0 for electronic informed consent, ePRO for patient-reported outcomes, and MediCLEO for patient recruitment. Supporting these digital solutions is a comprehensive suite of clinical development services covering Medical Writing, Project Management, Study Start-Up, Site Management & Monitoring, Data Management, Biostatistics, Quality Assurance, Centralized Monitoring, and Consulting. The portfolio enables hybrid digital clinical trials that integrate traditional site-based operations with decentralized elements for improved participant convenience and data quality.

Differentiator

Problem solved

Functional benefit

Brands

  • iSPERO: Decentralized clinical trial platform
  • cubeCONSENT 3.0
  • VIA/cubeRBQM
  • MediCLEO

Products and services

  • SPERO DCT (iSPERO)
  • VIA / cubeRBQM
  • MediCLEO
  • cubeCONSENT 3.0
  • ePRO (Electronic Patient-Reported Outcome)
  • Medical Writing
  • Project Management
  • Study Start-Up
  • Site Management & Monitoring
  • Data Management
  • Biostatistics
  • Quality Assurance
  • Centralized Monitoring (service)
  • Consulting Service

Quantifiable outcome

  • MediCLEO patient recruitment service has completed over 140 clinical studies

Companies that use Spero

Customer profile

Segments2 records

Ideal customer profiles1 record

Spero technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

Spero partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • CRScube Inc. (주)씨알에스큐브coreTechnology or Integration · 1 January 2022CRScube is a technology partner providing cubeCDMS (clinical data management system) and cubeCONSENT 3.0 electronic consent solution. Spero's VIA centralized monitoring solution has interlocking integration with cubeCDMS. The companies collaborate on DCT solutions with cubeCONSENT supporting electronic informed consent procedures integrated with Spero's clinical trial services.
  • CRScube Inc. (주)씨알에스큐브coreImplementation/ SI/ Consulting PartnerCRScube provides cloud server and web hosting services to Spero under a data processing delegation agreement. Services include customer support, technical measures for personal information safety including access control, encryption, and security program updates. Partnership supports Spero's digital infrastructure for clinical trial operations.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Spero competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: Global full-service CRO and clinical technology provider with extensive DCT capabilities through the IQVIA Decentralized Clinical Trials platform. Highly relevant as a broad incumbent that competes for the same pharma/biotech sponsors Spero targets, albeit at vastly larger scale.
  • Parexel: Large global CRO offering full-service clinical development plus decentralized and patient-centric trial solutions. Overlaps with Spero's CRO service portfolio (medical writing, monitoring, biostatistics, data management) for pharma and biotech sponsors.
  • Medidata Solutions: Clinical trial technology platform (Rave EDC, eCOA, eConsent, RBQM) widely used by sponsors and CROs. Direct overlap with Spero's iSPERO DCT platform, ePRO, eConsent, and VIA/cubeRBQM functionality, though Medidata is primarily a software provider serving many CROs.
  • Fortrea: Spin-off of Labcorp's clinical development business, providing full-service CRO services including decentralized trial enablement. Overlaps with Spero's full-service CRO portfolio (PM, monitoring, biostatistics, DM) at larger global scale.
  • Oracle Health Sciences: Provider of EDC (Oracle Clinical One), eClinical platform, and clinical trial analytics used by sponsors and CROs. Competes with Spero's data management, EDC integration, and centralized monitoring capabilities.

Direct peers

  • Medable: Dedicated decentralized clinical trial platform offering eConsent, eCOA, telehealth, and patient experience modules. Closely comparable to Spero's iSPERO stack in product scope and target customer (pharma/biotech sponsors running DCT and hybrid trials).
  • Science 37: DCT-native CRO and platform provider offering unified trial orchestration, eConsent, eCOA, and decentralized site services. Directly comparable to Spero's integrated CRO + DCT platform model.
  • Clario: Clinical trial endpoint technology and decentralized trial solutions provider with eCOA, medical imaging, and RBQM capabilities. Directly comparable to Spero's ePRO and centralized monitoring modules within a DCT offering.

Emerging players

  • CRScube: Korean clinical trial technology provider whose cubeCDMS, cubeCONSENT 3.0, and hosting services are integrated into Spero's iSPERO and VIA offerings. Adjacent competitor and partner in the Korean DCT ecosystem with overlapping DM and eConsent capabilities.
  • Curebase: DCT-focused clinical trial platform and provider offering eConsent, eCOA, remote monitoring, and a hybrid CRO service model. Comparable emerging peer with overlapping product modules and a similar SMB-CRO positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Spero social profiles

Digital presence

Spero financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Spero leadership team

Management profile

Number of profiles

Profiles1 record

Spero funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Spero M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Spero

What does Spero do?

Spero is a clinical research organization that delivers integrated decentralized clinical trial (DCT) solutions to pharmaceutical and biotech sponsors. It combines traditional clinical development services (medical writing, project management, study start-up, site management and monitoring, data management, biostatistics, quality assurance, centralized monitoring, and consulting) with proprietary digital tools including the iSPERO DCT platform, VIA/cubeRBQM centralized monitoring, cubeCONSENT 3.0 electronic consent, ePRO, and the MediCLEO patient recruitment service.

Is Spero a public or private company?

Spero is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Spero founded?

Spero was founded in 2022. It employs 1 to 10 people.

Where is Spero based?

Spero is headquartered in Seoul, South Korea, in the Asia region.

How does Spero make money?

Three revenue lines are on record. Clinical Development Services are the primary driver. The others are clinical Trial Solutions and clinical Trial Consultation.

Who are Spero's main competitors?

Broad incumbents on record are IQVIA, Parexel, Medidata Solutions, Fortrea and Oracle Health Sciences. Direct peers are Medable, Science 37 and Clario. Emerging players are CRScube and Curebase.

Does Spero have an API?

No public API is recorded for Spero.

What industry is Spero in?

Spero's product category is Clinical Research Organization (CRO) / Decentralized Clinical Trial Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAEAK, Point-of-Care & Decentralized Trial Testing Services. Its NAICS code is 541715 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales